NPTX2

NPTX2 Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
NP2-H52H6
Human
HEK293
Human NPTX2 Protein, His Tag (MALS verified)
Total: 1
  • 1

NPTX2 Background

Neuronal Pentraxin 2 (NPTX2), also named neuronal activity-regulated pentraxin, is a secreted glycoprotein characterized by a cyclic multimeric structure. In vivo, NTPX2 exerts various neurological effects by combining with the transmembrane protein neuronal pen traxin receptor (NPTXR). NPTX2 was thought to play a vital role in transmitting neurotrans mitters and maintaining synaptic plasticity. It also plays a role in clustering of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors at established synapses, resulting in non-apoptotic cell death of dopaminergic nerve cells. Up-regulation of this gene in Parkinson disease (PD) tissues suggests that the protein may be involved in the pathology of PD.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Paclitaxel/Hyaluronic acidPhase 3 ClinicalFidia PharmaCarcinoma, Papillary; Urinary Bladder Neoplasms
Details
Hydrogen peroxide/Hyaluronic acidBMG-0703Phase 3 ClinicalUniversity Of MilanPeriodontal Pocket; Bruxism; Gingival Hemorrhage; Gingivitis; Surgical Wound; Periodontitis
Details
CA-102NCA-102NPhase 2 ClinicalBiobudSolid tumours; Colorectal Neoplasms
Details
Multiple 4SCAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteBreast Neoplasms
Details
AMT-116(Multitude Therapeutics)AMT-116; AMT-116-ADCPhase 2 ClinicalMultitude Therapeutics IncSolid tumours; Head and Neck Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
CD44v6-specific CAR gene-engineered T cell therapy (Shenzhen Geno-Immune Medical Institute)4SCAR-CD44v6Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteNeoplasms
Details
Hyaluronic acid/FluorouracilHA-5FU; HA-5-fluorouracil; Hyaluronic acid-5-fluorouracil complex; Hyaluronan acid-5-fluorouracil complexPhase 2 ClinicalMonash University, Alchemia LtdColorectal Neoplasms
Details
AMC-303AMC-303; HP-558Phase 1 ClinicalAmcure GmbhSolid tumours; Esophageal Squamous Cell Carcinoma
Details
Clodronic acid/Hyaluronic acidPhase 1 ClinicalAbiogen Pharma SpaOsteoarthritis
Details
YN-001YN001; YN-001Phase 1 ClinicalBeijing Inno Medicine Co LtdPlaque, Atherosclerotic; Atherosclerosis; Cerebrovascular Disorders; Cardiovascular Diseases
Details
BGC-0228BGC-0228Phase 1 ClinicalSolid tumours
Details
Hyaluronic acid inhalation (Actelion Pharmaceuticals)ETX-100; CTX-100Actelion Pharmaceuticals Ltd
Details
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland